1 Study Coverage
1.1 Early Diagnosis Kit For Alzheimer’s Disease Product Introduction
1.2 Market by Sample Type
1.2.1 Global Early Diagnosis Kit For Alzheimer’s Disease Market Size Growth Rate by Sample Type, 2017 VS 2021 VS 2028
1.2.2 Blood
1.2.3 CSF
1.2.4 Others
1.3 Market by Application
1.3.1 Global Early Diagnosis Kit For Alzheimer’s Disease Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Medical
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Early Diagnosis Kit For Alzheimer’s Disease Sales Estimates and Forecasts 2017-2028
2.2 Global Early Diagnosis Kit For Alzheimer’s Disease Revenue Estimates and Forecasts 2017-2028
2.3 Global Early Diagnosis Kit For Alzheimer’s Disease Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Early Diagnosis Kit For Alzheimer’s Disease Sales by Region
2.4.1 Global Early Diagnosis Kit For Alzheimer’s Disease Sales by Region (2017-2022)
2.4.2 Global Sales Early Diagnosis Kit For Alzheimer’s Disease by Region (2023-2028)
2.5 Global Early Diagnosis Kit For Alzheimer’s Disease Revenue by Region
2.5.1 Global Early Diagnosis Kit For Alzheimer’s Disease Revenue by Region (2017-2022)
2.5.2 Global Early Diagnosis Kit For Alzheimer’s Disease Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Early Diagnosis Kit For Alzheimer’s Disease Sales by Manufacturers
3.1.1 Global Top Early Diagnosis Kit For Alzheimer’s Disease Manufacturers by Sales (2017-2022)
3.1.2 Global Early Diagnosis Kit For Alzheimer’s Disease Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Early Diagnosis Kit For Alzheimer’s Disease in 2021
3.2 Global Early Diagnosis Kit For Alzheimer’s Disease Revenue by Manufacturers
3.2.1 Global Early Diagnosis Kit For Alzheimer’s Disease Revenue by Manufacturers (2017-2022)
3.2.2 Global Early Diagnosis Kit For Alzheimer’s Disease Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Early Diagnosis Kit For Alzheimer’s Disease Revenue in 2021
3.3 Global Early Diagnosis Kit For Alzheimer’s Disease Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Early Diagnosis Kit For Alzheimer’s Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Early Diagnosis Kit For Alzheimer’s Disease Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Sample Type
4.1 Global Early Diagnosis Kit For Alzheimer’s Disease Sales by Sample Type
4.1.1 Global Early Diagnosis Kit For Alzheimer’s Disease Historical Sales by Sample Type (2017-2022)
4.1.2 Global Early Diagnosis Kit For Alzheimer’s Disease Forecasted Sales by Sample Type (2023-2028)
4.1.3 Global Early Diagnosis Kit For Alzheimer’s Disease Sales Market Share by Sample Type (2017-2028)
4.2 Global Early Diagnosis Kit For Alzheimer’s Disease Revenue by Sample Type
4.2.1 Global Early Diagnosis Kit For Alzheimer’s Disease Historical Revenue by Sample Type (2017-2022)
4.2.2 Global Early Diagnosis Kit For Alzheimer’s Disease Forecasted Revenue by Sample Type (2023-2028)
4.2.3 Global Early Diagnosis Kit For Alzheimer’s Disease Revenue Market Share by Sample Type (2017-2028)
4.3 Global Early Diagnosis Kit For Alzheimer’s Disease Price by Sample Type
4.3.1 Global Early Diagnosis Kit For Alzheimer’s Disease Price by Sample Type (2017-2022)
4.3.2 Global Early Diagnosis Kit For Alzheimer’s Disease Price Forecast by Sample Type (2023-2028)
5 Market Size by Application
5.1 Global Early Diagnosis Kit For Alzheimer’s Disease Sales by Application
5.1.1 Global Early Diagnosis Kit For Alzheimer’s Disease Historical Sales by Application (2017-2022)
5.1.2 Global Early Diagnosis Kit For Alzheimer’s Disease Forecasted Sales by Application (2023-2028)
5.1.3 Global Early Diagnosis Kit For Alzheimer’s Disease Sales Market Share by Application (2017-2028)
5.2 Global Early Diagnosis Kit For Alzheimer’s Disease Revenue by Application
5.2.1 Global Early Diagnosis Kit For Alzheimer’s Disease Historical Revenue by Application (2017-2022)
5.2.2 Global Early Diagnosis Kit For Alzheimer’s Disease Forecasted Revenue by Application (2023-2028)
5.2.3 Global Early Diagnosis Kit For Alzheimer’s Disease Revenue Market Share by Application (2017-2028)
5.3 Global Early Diagnosis Kit For Alzheimer’s Disease Price by Application
5.3.1 Global Early Diagnosis Kit For Alzheimer’s Disease Price by Application (2017-2022)
5.3.2 Global Early Diagnosis Kit For Alzheimer’s Disease Price Forecast by Application (2023-2028)
6 North America
6.1 North America Early Diagnosis Kit For Alzheimer’s Disease Market Size by Sample Type
6.1.1 North America Early Diagnosis Kit For Alzheimer’s Disease Sales by Sample Type (2017-2028)
6.1.2 North America Early Diagnosis Kit For Alzheimer’s Disease Revenue by Sample Type (2017-2028)
6.2 North America Early Diagnosis Kit For Alzheimer’s Disease Market Size by Application
6.2.1 North America Early Diagnosis Kit For Alzheimer’s Disease Sales by Application (2017-2028)
6.2.2 North America Early Diagnosis Kit For Alzheimer’s Disease Revenue by Application (2017-2028)
6.3 North America Early Diagnosis Kit For Alzheimer’s Disease Market Size by Country
6.3.1 North America Early Diagnosis Kit For Alzheimer’s Disease Sales by Country (2017-2028)
6.3.2 North America Early Diagnosis Kit For Alzheimer’s Disease Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Early Diagnosis Kit For Alzheimer’s Disease Market Size by Sample Type
7.1.1 Europe Early Diagnosis Kit For Alzheimer’s Disease Sales by Sample Type (2017-2028)
7.1.2 Europe Early Diagnosis Kit For Alzheimer’s Disease Revenue by Sample Type (2017-2028)
7.2 Europe Early Diagnosis Kit For Alzheimer’s Disease Market Size by Application
7.2.1 Europe Early Diagnosis Kit For Alzheimer’s Disease Sales by Application (2017-2028)
7.2.2 Europe Early Diagnosis Kit For Alzheimer’s Disease Revenue by Application (2017-2028)
7.3 Europe Early Diagnosis Kit For Alzheimer’s Disease Market Size by Country
7.3.1 Europe Early Diagnosis Kit For Alzheimer’s Disease Sales by Country (2017-2028)
7.3.2 Europe Early Diagnosis Kit For Alzheimer’s Disease Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Early Diagnosis Kit For Alzheimer’s Disease Market Size by Sample Type
8.1.1 Asia Pacific Early Diagnosis Kit For Alzheimer’s Disease Sales by Sample Type (2017-2028)
8.1.2 Asia Pacific Early Diagnosis Kit For Alzheimer’s Disease Revenue by Sample Type (2017-2028)
8.2 Asia Pacific Early Diagnosis Kit For Alzheimer’s Disease Market Size by Application
8.2.1 Asia Pacific Early Diagnosis Kit For Alzheimer’s Disease Sales by Application (2017-2028)
8.2.2 Asia Pacific Early Diagnosis Kit For Alzheimer’s Disease Revenue by Application (2017-2028)
8.3 Asia Pacific Early Diagnosis Kit For Alzheimer’s Disease Market Size by Region
8.3.1 Asia Pacific Early Diagnosis Kit For Alzheimer’s Disease Sales by Region (2017-2028)
8.3.2 Asia Pacific Early Diagnosis Kit For Alzheimer’s Disease Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Early Diagnosis Kit For Alzheimer’s Disease Market Size by Sample Type
9.1.1 Latin America Early Diagnosis Kit For Alzheimer’s Disease Sales by Sample Type (2017-2028)
9.1.2 Latin America Early Diagnosis Kit For Alzheimer’s Disease Revenue by Sample Type (2017-2028)
9.2 Latin America Early Diagnosis Kit For Alzheimer’s Disease Market Size by Application
9.2.1 Latin America Early Diagnosis Kit For Alzheimer’s Disease Sales by Application (2017-2028)
9.2.2 Latin America Early Diagnosis Kit For Alzheimer’s Disease Revenue by Application (2017-2028)
9.3 Latin America Early Diagnosis Kit For Alzheimer’s Disease Market Size by Country
9.3.1 Latin America Early Diagnosis Kit For Alzheimer’s Disease Sales by Country (2017-2028)
9.3.2 Latin America Early Diagnosis Kit For Alzheimer’s Disease Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Early Diagnosis Kit For Alzheimer’s Disease Market Size by Sample Type
10.1.1 Middle East and Africa Early Diagnosis Kit For Alzheimer’s Disease Sales by Sample Type (2017-2028)
10.1.2 Middle East and Africa Early Diagnosis Kit For Alzheimer’s Disease Revenue by Sample Type (2017-2028)
10.2 Middle East and Africa Early Diagnosis Kit For Alzheimer’s Disease Market Size by Application
10.2.1 Middle East and Africa Early Diagnosis Kit For Alzheimer’s Disease Sales by Application (2017-2028)
10.2.2 Middle East and Africa Early Diagnosis Kit For Alzheimer’s Disease Revenue by Application (2017-2028)
10.3 Middle East and Africa Early Diagnosis Kit For Alzheimer’s Disease Market Size by Country
10.3.1 Middle East and Africa Early Diagnosis Kit For Alzheimer’s Disease Sales by Country (2017-2028)
10.3.2 Middle East and Africa Early Diagnosis Kit For Alzheimer’s Disease Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 QuantaMatrix
11.1.1 QuantaMatrix Corporation Information
11.1.2 QuantaMatrix Overview
11.1.3 QuantaMatrix Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 QuantaMatrix Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 QuantaMatrix Recent Developments
11.2 MIND and Tech
11.2.1 MIND and Tech Corporation Information
11.2.2 MIND and Tech Overview
11.2.3 MIND and Tech Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 MIND and Tech Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 MIND and Tech Recent Developments
11.3 Immuno-Biological Laboratories
11.3.1 Immuno-Biological Laboratories Corporation Information
11.3.2 Immuno-Biological Laboratories Overview
11.3.3 Immuno-Biological Laboratories Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Immuno-Biological Laboratories Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Immuno-Biological Laboratories Recent Developments
11.4 PeopleBio
11.4.1 PeopleBio Corporation Information
11.4.2 PeopleBio Overview
11.4.3 PeopleBio Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 PeopleBio Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 PeopleBio Recent Developments
11.5 Health Biotech
11.5.1 Health Biotech Corporation Information
11.5.2 Health Biotech Overview
11.5.3 Health Biotech Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Health Biotech Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Health Biotech Recent Developments
11.6 ScienCell
11.6.1 ScienCell Corporation Information
11.6.2 ScienCell Overview
11.6.3 ScienCell Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 ScienCell Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 ScienCell Recent Developments
11.7 Paragon Genomics
11.7.1 Paragon Genomics Corporation Information
11.7.2 Paragon Genomics Overview
11.7.3 Paragon Genomics Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Paragon Genomics Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Paragon Genomics Recent Developments
11.8 Solgent
11.8.1 Solgent Corporation Information
11.8.2 Solgent Overview
11.8.3 Solgent Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Solgent Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Solgent Recent Developments
11.9 FUJIFILM Cellular Dynamics (FCDI)
11.9.1 FUJIFILM Cellular Dynamics (FCDI) Corporation Information
11.9.2 FUJIFILM Cellular Dynamics (FCDI) Overview
11.9.3 FUJIFILM Cellular Dynamics (FCDI) Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 FUJIFILM Cellular Dynamics (FCDI) Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 FUJIFILM Cellular Dynamics (FCDI) Recent Developments
11.10 MyBioSource
11.10.1 MyBioSource Corporation Information
11.10.2 MyBioSource Overview
11.10.3 MyBioSource Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 MyBioSource Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 MyBioSource Recent Developments
11.11 Quanterix
11.11.1 Quanterix Corporation Information
11.11.2 Quanterix Overview
11.11.3 Quanterix Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Quanterix Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Quanterix Recent Developments
11.12 Roche Diagnostics
11.12.1 Roche Diagnostics Corporation Information
11.12.2 Roche Diagnostics Overview
11.12.3 Roche Diagnostics Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Roche Diagnostics Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Roche Diagnostics Recent Developments
11.13 Fujirebio
11.13.1 Fujirebio Corporation Information
11.13.2 Fujirebio Overview
11.13.3 Fujirebio Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Fujirebio Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Fujirebio Recent Developments
11.14 BioArctic
11.14.1 BioArctic Corporation Information
11.14.2 BioArctic Overview
11.14.3 BioArctic Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 BioArctic Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 BioArctic Recent Developments
11.15 ADmit Therapeutics
11.15.1 ADmit Therapeutics Corporation Information
11.15.2 ADmit Therapeutics Overview
11.15.3 ADmit Therapeutics Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 ADmit Therapeutics Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 ADmit Therapeutics Recent Developments
11.16 Amoneta Diagnostics
11.16.1 Amoneta Diagnostics Corporation Information
11.16.2 Amoneta Diagnostics Overview
11.16.3 Amoneta Diagnostics Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Amoneta Diagnostics Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Amoneta Diagnostics Recent Developments
11.17 Cisbio
11.17.1 Cisbio Corporation Information
11.17.2 Cisbio Overview
11.17.3 Cisbio Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Cisbio Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Cisbio Recent Developments
11.18 BioVision
11.18.1 BioVision Corporation Information
11.18.2 BioVision Overview
11.18.3 BioVision Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 BioVision Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 BioVision Recent Developments
11.19 Fujifilm
11.19.1 Fujifilm Corporation Information
11.19.2 Fujifilm Overview
11.19.3 Fujifilm Early Diagnosis Kit For Alzheimer’s Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Fujifilm Early Diagnosis Kit For Alzheimer’s Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Fujifilm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Early Diagnosis Kit For Alzheimer’s Disease Industry Chain Analysis
12.2 Early Diagnosis Kit For Alzheimer’s Disease Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Early Diagnosis Kit For Alzheimer’s Disease Production Mode & Process
12.4 Early Diagnosis Kit For Alzheimer’s Disease Sales and Marketing
12.4.1 Early Diagnosis Kit For Alzheimer’s Disease Sales Channels
12.4.2 Early Diagnosis Kit For Alzheimer’s Disease Distributors
12.5 Early Diagnosis Kit For Alzheimer’s Disease Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Early Diagnosis Kit For Alzheimer’s Disease Industry Trends
13.2 Early Diagnosis Kit For Alzheimer’s Disease Market Drivers
13.3 Early Diagnosis Kit For Alzheimer’s Disease Market Challenges
13.4 Early Diagnosis Kit For Alzheimer’s Disease Market Restraints
14 Key Findings in The Global Early Diagnosis Kit For Alzheimer’s Disease Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
アルツハイマー病早期診断キットの世界市場インサイト・予測（～2028年） |
| 【英語タイトル】Global Early Diagnosis Kit For Alzheimer's Disease Market Insights, Forecast to 2028 | |
 | ・商品コード：QY22JL3515 ・発行会社（調査会社）：QYResearch ・発行日：2022年7月（※2025年版があります。お問い合わせください。） ・ページ数：117 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後3営業日） ・調査対象地域：グローバル ・産業分野：医療機器 |
| Single User（1名様閲覧用） | USD4,900 ⇒換算￥744,800 | 見積依頼/購入/質問フォーム |
| Multi User（5名様閲覧用） | USD7,350 ⇒換算￥1,117,200 | 見積依頼/購入/質問フォーム |
| Enterprise License（同一法人内共有可） | USD9,800 ⇒換算￥1,489,600 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| COVID-19のパンデミックにより、アルツハイマー病早期診断キットのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にアルツハイマー病早期診断キットの世界市場のxxx％を占める「血液」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「医療」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 アルツハイマー病早期診断キットの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのアルツハイマー病早期診断キット市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 アルツハイマー病早期診断キットのグローバル主要企業には、QuantaMatrix、MIND and Tech、Immuno-Biological Laboratories、PeopleBio、Health Biotech、ScienCell、Paragon Genomics、Solgent、FUJIFILM Cellular Dynamics (FCDI)、MyBioSource、Quanterix、Roche Diagnostics、Fujirebio、BioArctic、ADmit Therapeutics、Amoneta Diagnostics、Cisbio、BioVision、Fujifilmなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 アルツハイマー病早期診断キット市場は、種類と用途によって区分されます。世界のアルツハイマー病早期診断キット市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 血液、CSF、その他 【用途別セグメント】 医療、研究 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - アルツハイマー病早期診断キット製品概要 - 種類別市場（血液、CSF、その他） - 用途別市場（医療、研究） - 調査の目的 ・エグゼクティブサマリー - 世界のアルツハイマー病早期診断キット販売量予測2017-2028 - 世界のアルツハイマー病早期診断キット売上予測2017-2028 - アルツハイマー病早期診断キットの地域別販売量 - アルツハイマー病早期診断キットの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別アルツハイマー病早期診断キット販売量 - 主要メーカー別アルツハイマー病早期診断キット売上 - 主要メーカー別アルツハイマー病早期診断キット価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（血液、CSF、その他） - アルツハイマー病早期診断キットの種類別販売量 - アルツハイマー病早期診断キットの種類別売上 - アルツハイマー病早期診断キットの種類別価格 ・用途別市場規模（医療、研究） - アルツハイマー病早期診断キットの用途別販売量 - アルツハイマー病早期診断キットの用途別売上 - アルツハイマー病早期診断キットの用途別価格 ・北米市場 - 北米のアルツハイマー病早期診断キット市場規模（種類別、用途別） - 主要国別のアルツハイマー病早期診断キット市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのアルツハイマー病早期診断キット市場規模（種類別、用途別） - 主要国別のアルツハイマー病早期診断キット市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のアルツハイマー病早期診断キット市場規模（種類別、用途別） - 主要国別のアルツハイマー病早期診断キット市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のアルツハイマー病早期診断キット市場規模（種類別、用途別） - 主要国別のアルツハイマー病早期診断キット市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのアルツハイマー病早期診断キット市場規模（種類別、用途別） - 主要国別のアルツハイマー病早期診断キット市場規模（トルコ、サウジアラビア） ・企業情報 QuantaMatrix、MIND and Tech、Immuno-Biological Laboratories、PeopleBio、Health Biotech、ScienCell、Paragon Genomics、Solgent、FUJIFILM Cellular Dynamics (FCDI)、MyBioSource、Quanterix、Roche Diagnostics、Fujirebio、BioArctic、ADmit Therapeutics、Amoneta Diagnostics、Cisbio、BioVision、Fujifilm ・産業チェーン及び販売チャネル分析 - アルツハイマー病早期診断キットの産業チェーン分析 - アルツハイマー病早期診断キットの原材料 - アルツハイマー病早期診断キットの生産プロセス - アルツハイマー病早期診断キットの販売及びマーケティング - アルツハイマー病早期診断キットの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - アルツハイマー病早期診断キットの産業動向 - アルツハイマー病早期診断キットのマーケットドライバー - アルツハイマー病早期診断キットの課題 - アルツハイマー病早期診断キットの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Early Diagnosis Kit For Alzheimer’s Disease Market
Due to the COVID-19 pandemic, the global Early Diagnosis Kit For Alzheimer’s Disease market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Blood accounting for % of the Early Diagnosis Kit For Alzheimer’s Disease global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Medical segment is altered to an % CAGR throughout this forecast period.
China Early Diagnosis Kit For Alzheimer’s Disease market size is valued at US$ million in 2021, while the US and Europe Early Diagnosis Kit For Alzheimer’s Disease are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Early Diagnosis Kit For Alzheimer’s Disease landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Early Diagnosis Kit For Alzheimer’s Disease include QuantaMatrix, MIND and Tech, Immuno-Biological Laboratories, PeopleBio, Health Biotech, ScienCell, Paragon Genomics, Solgent and FUJIFILM Cellular Dynamics (FCDI), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Early Diagnosis Kit For Alzheimer’s Disease Scope and Segment
Early Diagnosis Kit For Alzheimer’s Disease market is segmented by Sample Type and by Application. Players, stakeholders, and other participants in the global Early Diagnosis Kit For Alzheimer’s Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Sample Type and by Application for the period 2017-2028.
Segment by Sample Type
Blood
CSF
Others
Segment by Application
Medical
Research
By Company
QuantaMatrix
MIND and Tech
Immuno-Biological Laboratories
PeopleBio
Health Biotech
ScienCell
Paragon Genomics
Solgent
FUJIFILM Cellular Dynamics (FCDI)
MyBioSource
Quanterix
Roche Diagnostics
Fujirebio
BioArctic
ADmit Therapeutics
Amoneta Diagnostics
Cisbio
BioVision
Fujifilm
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
❖ レポートの目次 ❖
| ★調査レポート[アルツハイマー病早期診断キットの世界市場インサイト・予測（～2028年）] (コード：QY22JL3515)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[アルツハイマー病早期診断キットの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ |
